ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes

ClinicalTrials.gov ID: NCT01272219

Public ClinicalTrials.gov record NCT01272219. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: A Randomised, Double-blind, Placebo Controlled, Parallel Group, Multi-centre, Multinational Trial With Stratification of Subject to Either 56 or 160 Weeks of Treatment Based on Pre-diabetes Status at Randomisation

Study identification

NCT ID
NCT01272219
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
3,731 participants

Conditions and interventions

Interventions

  • liraglutide Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2011
Primary completion
Mar 17, 2013
Completion
Mar 1, 2015
Last update posted
Jan 18, 2018

2011 – 2015

United States locations

U.S. sites
73
U.S. states
27
U.S. cities
67
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35205-4731
Novo Nordisk Investigational Site Phoenix Arizona 85027
Novo Nordisk Investigational Site Anaheim California 92801
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Huntington Beach California 92646
Novo Nordisk Investigational Site La Jolla California 92037
Novo Nordisk Investigational Site San Diego California 92103-4140
Novo Nordisk Investigational Site San Diego California 92108
Novo Nordisk Investigational Site Santa Monica California 90404
Novo Nordisk Investigational Site Aurora Colorado 80045
Novo Nordisk Investigational Site Colorado Springs Colorado 80904
Novo Nordisk Investigational Site Golden Colorado 80401
Novo Nordisk Investigational Site New London Connecticut 06320
Novo Nordisk Investigational Site Waterbury Connecticut 06708
Novo Nordisk Investigational Site Washington D.C. District of Columbia 20036-5847
Novo Nordisk Investigational Site Boynton Beach Florida 33437
Novo Nordisk Investigational Site Bradenton Florida 34201
Novo Nordisk Investigational Site Crystal River Florida 34429
Novo Nordisk Investigational Site Daytona Beach Florida 32117
Novo Nordisk Investigational Site Jacksonville Florida 32205
Novo Nordisk Investigational Site Jacksonville Florida 32216
Novo Nordisk Investigational Site Ocala Florida 34471
Novo Nordisk Investigational Site Ponte Vedra Florida 32081
Novo Nordisk Investigational Site South Miami Florida 33143
Novo Nordisk Investigational Site Athens Georgia 30606
Novo Nordisk Investigational Site Dunwoody Georgia 30338
Novo Nordisk Investigational Site Sandy Springs Georgia 30328
Novo Nordisk Investigational Site Suwanee Georgia 30024
Novo Nordisk Investigational Site Aurora Illinois 60504
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site Baton Rouge Louisiana 70808-4124
Novo Nordisk Investigational Site Baltimore Maryland 21209
Novo Nordisk Investigational Site Elkridge Maryland 21075-6437
Novo Nordisk Investigational Site North Dartmouth Massachusetts 02747
Novo Nordisk Investigational Site City of Saint Peters Missouri 63376
Novo Nordisk Investigational Site Kansas City Missouri 64111
Novo Nordisk Investigational Site St Louis Missouri 63104
Novo Nordisk Investigational Site St Louis Missouri 63141
Novo Nordisk Investigational Site New York New York 10025
Novo Nordisk Investigational Site Rochester New York 14609
Novo Nordisk Investigational Site Staten Island New York 10301
Novo Nordisk Investigational Site Syracuse New York 13210
Novo Nordisk Investigational Site Cary North Carolina 27518
Novo Nordisk Investigational Site Raleigh North Carolina 27612
Novo Nordisk Investigational Site Canal Fulton Ohio 44614
Novo Nordisk Investigational Site Cincinnati Ohio 45219
Novo Nordisk Investigational Site Franklin Ohio 45005
Novo Nordisk Investigational Site Wadsworth Ohio 44281-9236
Novo Nordisk Investigational Site Tulsa Oklahoma 74136
Novo Nordisk Investigational Site Eugene Oregon 97401
Novo Nordisk Investigational Site Beaver Pennsylvania 15009
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15206
Novo Nordisk Investigational Site West Reading Pennsylvania 19611
Novo Nordisk Investigational Site Charleston South Carolina 29425
Novo Nordisk Investigational Site Greer South Carolina 29651
Novo Nordisk Investigational Site Bristol Tennessee 37620-7352
Novo Nordisk Investigational Site Austin Texas 78731
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Dallas Texas 75234
Novo Nordisk Investigational Site Dallas Texas 75251
Novo Nordisk Investigational Site Dallas Texas 75390-8858
Novo Nordisk Investigational Site San Antonio Texas 78229-4801
Novo Nordisk Investigational Site Sugar Land Texas 77479
Novo Nordisk Investigational Site Salt Lake City Utah 84107
Novo Nordisk Investigational Site West Jordan Utah 84088-8871
Novo Nordisk Investigational Site Arlington Virginia 22206
Novo Nordisk Investigational Site Henrico Virginia 23233
Novo Nordisk Investigational Site Richmond Virginia 23294
Novo Nordisk Investigational Site Virginia Beach Virginia 23454
Novo Nordisk Investigational Site Renton Washington 98057
Novo Nordisk Investigational Site Wenatchee Washington 98801-2028
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 153 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01272219, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2018 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01272219 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →